246.30
0.00
(0.00%)
At close: January 13 at 4:09:11 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 11 | 11 | 16 | 15 |
| Avg. Estimate | 43.58B | 43.92B | 174.55B | 179.93B |
| Low Estimate | 42.5B | 43.08B | 163.62B | 161.5B |
| High Estimate | 44.67B | 45B | 181B | 190B |
| Year Ago Sales | 41.93B | 50.2B | 177.56B | 174.55B |
| Sales Growth (year/est) | 3.94% | -12.51% | -1.69% | 3.08% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 4JPM.TI | -- | -- | -- | -- |
| S&P 500 | 9.26% | 11.36% | 13.91% | 13.52% |
Upgrades & Downgrades
| Maintains | UBS: Buy to Buy | 1/16/2025 |
| Maintains | Barclays: Overweight to Overweight | 1/16/2025 |
| Maintains | Keefe, Bruyette & Woods: Market Perform to Market Perform | 1/16/2025 |
| Maintains | Truist Securities: Hold to Hold | 1/16/2025 |
| Maintains | B of A Securities: Buy to Buy | 1/7/2025 |
| Initiated | Truist Securities: Hold | 1/7/2025 |